• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

First-line antiretroviral therapy in resource-limited settings: time to reconsider?

作者信息

Adlington Rebecca, Richens John, Shahmanesh Maryam

出版信息

J Infect Dis. 2009 May 1;199(9):1407; author reply 1407-8. doi: 10.1086/597809.

DOI:10.1086/597809
PMID:19358673
Abstract
摘要

相似文献

1
First-line antiretroviral therapy in resource-limited settings: time to reconsider?资源有限环境下的一线抗逆转录病毒疗法：是时候重新考虑了吗？
J Infect Dis. 2009 May 1;199(9):1407; author reply 1407-8. doi: 10.1086/597809.
2
Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.世界卫生组织一线治疗方案（司他夫定/拉米夫定/奈韦拉平）在西方环境中初治抗逆转录病毒治疗个体中的疗效。
HIV Med. 2007 Jul;8(5):267-70. doi: 10.1111/j.1468-1293.2007.00463.x.
3
Drug resistance after failure of initial antiretroviral therapy in resource-limited countries.资源有限国家初始抗逆转录病毒治疗失败后的耐药性
Clin Infect Dis. 2007 Feb 1;44(3):453-5. doi: 10.1086/510752. Epub 2006 Dec 27.
4
Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.喀麦隆一组感染1型艾滋病毒患者在接受一线抗逆转录病毒治疗方案不同疗程后的耐药情况。
Antivir Ther. 2009;14(3):339-47.
5
Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.基于非核苷类逆转录酶抑制剂的高效抗逆转录病毒疗法在泰国2岁及以下感染艾滋病毒儿童中的疗效。
Pediatr Infect Dis J. 2009 Mar;28(3):246-8. doi: 10.1097/INF.0b013e31818dd72b.
6
HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.接受基于非核苷类逆转录酶抑制剂的抗逆转录病毒治疗失败的儿童中的HIV-1耐药性突变
Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):83-8.
7
Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a review.面对HIV-1核苷类逆转录酶抑制剂之间的交叉耐药性时的司他夫定：综述
AIDS Rev. 2003 Apr-Jun;5(2):80-6.
8
A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.对新兴国家获取抗逆转录病毒药物组合至关重要的活性药物成分合成情况的调查。
Antiviral Res. 2008 Sep;79(3):143-65. doi: 10.1016/j.antiviral.2008.05.001. Epub 2008 Jun 2.
9
Salvage therapy with amprenavir, lopinavir and ritonavir is durably potent in HIV-infected patients in virological failure: 1-year results.
AIDS. 2007 Jan 11;21(2):241-3. doi: 10.1097/QAD.0b013e3280118d6a.
10
[Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].[高效抗逆转录病毒治疗中断后出现的单核细胞增多症综合征，其病毒免疫参数与原发性HIV-1感染相似]
An Med Interna. 2002 Jun;19(6):321-2.

引用本文的文献

1
HIV-1 genetic diversity and drug resistance among Senegalese patients in the public health system.HIV-1 基因多样性和耐药性在塞内加尔公共卫生系统中的患者。
J Clin Microbiol. 2013 Feb;51(2):578-84. doi: 10.1128/JCM.02452-12. Epub 2012 Dec 12.
2
Adherence to antiretroviral therapy and treatment outcomes among conflict-affected and forcibly displaced populations: a systematic review.受冲突影响和被迫流离失所人群中抗逆转录病毒治疗的依从性和治疗结局：系统评价。
Confl Health. 2012 Oct 31;6(1):9. doi: 10.1186/1752-1505-6-9.
3
First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial.
南非单次奈韦拉平暴露后一线抗逆转录病毒治疗：OCTANE 试验的成本效益分析。
AIDS. 2011 Feb 20;25(4):479-92. doi: 10.1097/QAD.0b013e3283428cbe.
4
Antiretroviral (ARV) Therapy in Resource Poor Countries: What do we Need in Real Life?资源匮乏国家的抗逆转录病毒疗法：现实生活中我们需要什么？
Open AIDS J. 2010 Jan 19;4:28-32. doi: 10.2174/1874613601004020028.